Literature DB >> 12447775

Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands.

James R Johnson1, Cindy van der Schee, Michael A Kuskowski, Wil Goessens, Alex van Belkum.   

Abstract

Thirteen fluoroquinolone-resistant Escherichia coli (FQREC) isolates from hospitalized patients in the Netherlands were found to represent predominantly (low-virulence) phylogenetic groups A and B1 and to lack extraintestinal virulence traits. These FQREC resemble animal-source E. coli and presumably pose little threat to noncompromised hosts. Similar analysis of other FQREC is needed.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12447775     DOI： 10.1086/345767

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  24 in total

1.  High-frequency secondary mutations after suicide-driven allelic exchange mutagenesis in extraintestinal pathogenic Escherichia coli.

Authors:  James R Johnson; Hank A Lockman; Krista Owens; Srdjan Jelacic; Phillip I Tarr
Journal:  J Bacteriol       Date:  2003-09       Impact factor: 3.490

2.  Integration of pharmacokinetic and pharmacodynamic indices of marbofloxacin in turkeys.

Authors:  Aneliya Milanova Haritova; Nikolina Velizarova Rusenova; Parvan Rusenov Parvanov; Lubomir Dimitrov Lashev; Johanna Fink-Gremmels
Journal:  Antimicrob Agents Chemother       Date:  2006-08-28       Impact factor: 5.191

3.  Virulence factors in Escherichia coli.

Authors:  James R Johnson
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis.

Authors:  James R Johnson; Michael A Kuskowski; Timothy T O'bryan; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

5.  Spontaneous conversion to quinolone and fluoroquinolone resistance among wild-type Escherichia coli isolates in relation to phylogenetic background and virulence genotype.

Authors:  James R Johnson; Brian Johnston; Michael A Kuskowski; Raul Colodner; Raul Raz
Journal:  Antimicrob Agents Chemother       Date:  2005-11       Impact factor: 5.191

6.  Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts.

Authors:  Juan P Horcajada; Sara Soto; Abby Gajewski; Alex Smithson; M Teresa Jiménez de Anta; Josep Mensa; Jordi Vila; James R Johnson
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

7.  Molecular Characterization of Uropathogenic Escherichia coli: Nalidixic Acid and Ciprofloxacin Resistance, Virulent Factors and Phylogenetic Background.

Authors:  Shreya Basu; Sandip Kumar Mukherjee; Avijit Hazra; Mandira Mukherjee
Journal:  J Clin Diagn Res       Date:  2013-12-15

8.  Molecular analysis of antimicrobial-susceptible and -resistant Escherichia coli from retail meats and human stool and clinical specimens in a rural community setting.

Authors:  Elizabeth Lyon Hannah; James R Johnson; Frederick Angulo; Bassam Haddadin; Jacquelyn Williamson; Matthew H Samore
Journal:  Foodborne Pathog Dis       Date:  2009-04       Impact factor: 3.171

9.  Insights into the environmental resistance gene pool from the genome sequence of the multidrug-resistant environmental isolate Escherichia coli SMS-3-5.

Authors:  W Florian Fricke; Meredith S Wright; Angela H Lindell; Derek M Harkins; Craig Baker-Austin; Jacques Ravel; Ramunas Stepanauskas
Journal:  J Bacteriol       Date:  2008-08-15       Impact factor: 3.490

10.  Extraintestinal pathogenic Escherichia coli O1:K1:H7/NM from human and avian origin: detection of clonal groups B2 ST95 and D ST59 with different host distribution.

Authors:  Azucena Mora; Cecilia López; Ghizlane Dabhi; Miguel Blanco; Jesús E Blanco; María Pilar Alonso; Alexandra Herrera; Rosalía Mamani; Stéphane Bonacorsi; Maryvonne Moulin-Schouleur; Jorge Blanco
Journal:  BMC Microbiol       Date:  2009-07-07       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.